Terms: = Pancreatic cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
26 results:
1. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic il7r in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
2. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
Jang SI; Lee HK; Chang EJ; Kim S; Kim SY; Hong IY; Kim JK; Lee HS; Yang J; Cho JH; Lee DK
Cancer Immunol Immunother; 2023 Aug; 72(8):2757-2768. PubMed ID: 37165046
[TBL] [Abstract] [Full Text] [Related]
3. Glutamine deprivation induces ferroptosis in pancreatic cancer cells.
Xiao Z; Deng S; Liu H; Wang R; Liu Y; Dai Z; Gu W; Ni Q; Yu X; Liu C; Luo G
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(8):1288-1300. PubMed ID: 36942991
[TBL] [Abstract] [Full Text] [Related]
4. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
[TBL] [Abstract] [Full Text] [Related]
5. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Leung SS; Borg DJ; McCarthy DA; Boursalian TE; Cracraft J; Zhuang A; Fotheringham AK; Flemming N; Watkins T; Miles JJ; Groop PH; Scheijen JL; Schalkwijk CG; Steptoe RJ; Radford KJ; Knip M; Forbes JM
Diabetes; 2022 Sep; 71(9):1994-2008. PubMed ID: 35713929
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers.
Zheng C; Fass JN; Shih YP; Gunderson AJ; Sanjuan Silva N; Huang H; Bernard BM; Rajamanickam V; Slagel J; Bifulco CB; Piening B; Newell PHA; Hansen PD; Tran E
Cancer Cell; 2022 Apr; 40(4):410-423.e7. PubMed ID: 35413272
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Caushi JX; Zhang J; Ji Z; Vaghasia A; Zhang B; Hsiue EH; Mog BJ; Hou W; Justesen S; Blosser R; Tam A; Anagnostou V; Cottrell TR; Guo H; Chan HY; Singh D; Thapa S; Dykema AG; Burman P; Choudhury B; Aparicio L; Cheung LS; Lanis M; Belcaid Z; El Asmar M; Illei PB; Wang R; Meyers J; Schuebel K; Gupta A; Skaist A; Wheelan S; Naidoo J; Marrone KA; Brock M; Ha J; Bush EL; Park BJ; Bott M; Jones DR; Reuss JE; Velculescu VE; Chaft JE; Kinzler KW; Zhou S; Vogelstein B; Taube JM; Hellmann MD; Brahmer JR; Merghoub T; Forde PM; Yegnasubramanian S; Ji H; Pardoll DM; Smith KN
Nature; 2021 Aug; 596(7870):126-132. PubMed ID: 34290408
[TBL] [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of endoscopic resection for colorectal laterally spreading tumors: Endoscopic submucosal dissection versus piecemeal endoscopic mucosal resection.
Sekiguchi M; Igarashi A; Mizuguchi Y; Takamaru H; Yamada M; Sakamoto T; Maltzman H; Falkén Y; Esaki M; Matsuda T; Saito Y
Dig Endosc; 2022 Mar; 34(3):553-568. PubMed ID: 34101915
[TBL] [Abstract] [Full Text] [Related]
9. Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patients.
Liu MF; Jin C; Wu T; Chen EH; Lu M; Qin HL
Immunol Res; 2021 Jun; 69(3):275-284. PubMed ID: 33959834
[TBL] [Abstract] [Full Text] [Related]
10. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of pancreatic cancer.
Ma Y; Li J; Wang H; Chiu Y; Kingsley CV; Fry D; Delaney SN; Wei SC; Zhang J; Maitra A; Yee C
Gastroenterology; 2020 Jul; 159(1):306-319.e12. PubMed ID: 32179091
[TBL] [Abstract] [Full Text] [Related]
11. Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.
Qiao G; Wang X; Zhou X; Morse MA; Wu J; Wang S; Song Y; Jiang N; Zhao Y; Zhou L; Zhao J; Di Y; Zhu L; Hobeika A; Ren J; Lyerly HK
Int J Hyperthermia; 2019 Nov; 36(sup1):74-82. PubMed ID: 31795830
[No Abstract] [Full Text] [Related]
12. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
[TBL] [Abstract] [Full Text] [Related]
13. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer.
Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Cancer Med; 2019 Sep; 8(11):5194-5201. PubMed ID: 31353821
[TBL] [Abstract] [Full Text] [Related]
14. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
[TBL] [Abstract] [Full Text] [Related]
15. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract] [Full Text] [Related]
16. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.
Liu C; Cheng H; Luo G; Lu Y; Jin K; Guo M; Ni Q; Yu X
Int J Oncol; 2017 Aug; 51(2):686-694. PubMed ID: 28714519
[TBL] [Abstract] [Full Text] [Related]
17. Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
Zhai N; Li H; Song H; Yang Y; Cui A; Li T; Niu J; Crispe IN; Su L; Tu Z
PLoS One; 2017; 12(1):e0170516. PubMed ID: 28114346
[TBL] [Abstract] [Full Text] [Related]
18. Variation of cytopathologists' use of the indeterminate diagnostic categories "atypical" and "suspicious for malignancy" in the cytologic diagnosis of solid pancreatic lesions on endoscopic ultrasound-guided fine-needle aspirates.
Virk RK; Gamez R; Mehrotra S; Atieh M; Barkan GA; Wojcik EM; Pambuccian SE
Diagn Cytopathol; 2017 Jan; 45(1):3-13. PubMed ID: 27873469
[TBL] [Abstract] [Full Text] [Related]
19. Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection.
Ichida A; Hasegawa K; Takayama T; Kudo H; Sakamoto Y; Yamazaki S; Midorikawa Y; Higaki T; Matsuyama Y; Kokudo N
Br J Surg; 2016 Dec; 103(13):1795-1803. PubMed ID: 27682642
[TBL] [Abstract] [Full Text] [Related]
20. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.
Xu YF; Lu Y; Cheng H; Shi S; Xu J; Long J; Liu L; Liu C; Yu X
Pancreatology; 2014; 14(4):295-301. PubMed ID: 25062880
[TBL] [Abstract] [Full Text] [Related]
[Next]
